When treating multiple EphA2+ GBM cell lines with optimized CAR T cell design, treatment showed tumor cell lysis with significant upregulation of interferon gamma and IL-2, and only low levels of induced inhibitory cytokines IL-10 and IL-4 [72]. This evidence concerns the gene IL2 and glioblastoma.